(Q45858725)

PubMed publication ID

20427771

17 December 2017

http://europepmc.org/abstract/MED/20427771

title

Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

Nicholas P. Restifo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

9

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

7

Zhili Zheng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

Dhanalakshmi Chinnasamy

5

object named as

Dhanalakshmi Chinnasamy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

6

Jennifer A Wargo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

author name string

William R Burns

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

Peter D Peng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

Zhiya Yu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

Richard A Morgan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

28 April 2010

1 reference

PubMed publication ID

20427771

17 December 2017

http://europepmc.org/abstract/MED/20427771

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

volume

184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

page(s)

5988-5998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

13 May 2020

cites work

1 reference

12 December 2020

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

1 reference

12 December 2020

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

12 December 2020

MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte

1 reference

12 December 2020

Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.

1 reference

12 December 2020

Selecting highly affine and well-expressed TCRs for gene therapy of melanoma

1 reference

12 December 2020

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

12 December 2020

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

1 reference

12 December 2020

CD4 cells can be more efficient at tumor rejection than CD8 cells

1 reference

12 December 2020

Pre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapy

1 reference

12 December 2020

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

1 reference

12 December 2020

Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens

1 reference

12 December 2020

Gene splicing and mutagenesis by PCR-driven overlap extension

1 reference

12 December 2020

Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray

1 reference

12 December 2020

Plat-E: an efficient and stable system for transient packaging of retroviruses

1 reference

12 December 2020

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

1 reference

12 December 2020

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

12 December 2020

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

1 reference

12 December 2020

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.

1 reference

12 December 2020

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions

1 reference

12 December 2020

Facilitating matched pairing and expression of TCR chains introduced into human T cells

1 reference

12 December 2020

Stable, soluble T-cell receptor molecules for crystallization and therapeutics

1 reference

12 December 2020

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

1 reference

12 December 2020

Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition

1 reference

12 December 2020

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

1 reference

12 December 2020

Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.

1 reference

12 December 2020

Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.

1 reference

12 December 2020

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation

1 reference

12 December 2020

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

12 December 2020

Primary antitumor immune response mediated by CD4+ T cells

1 reference

12 December 2020

Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions

1 reference

12 December 2020

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

1 reference

12 December 2020

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

12 December 2020

Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence of in vivo priming by tumor cells

1 reference

12 December 2020

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

12 December 2020

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

12 December 2020

Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo

1 reference

12 December 2020

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

1 reference

12 December 2020

A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes

1 reference

12 December 2020

Human melanoma antigens recognized by T lymphocytes

1 reference

12 December 2020

Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy

1 reference

12 December 2020

Immunophenotyping of melanomas for tyrosinase: implications for vaccine development

1 reference

12 December 2020

Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.

1 reference

12 December 2020

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

12 December 2020

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

1 reference

12 December 2020

Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression

1 reference

12 December 2020

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro.

1 reference

12 December 2020

A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes

1 reference

12 December 2020

Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes

1 reference

12 December 2020

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.

1 reference

12 December 2020

Identifiers

DOI

10.4049/JIMMUNOL.1000189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6290481&resulttype=core&format=json

13 May 2020

PubMed publication ID

20427771

1 reference